Ionis Pharmaceuticals Inc (IONS) is down Monday morning, with the stock declining -7.41% in pre-market trading to 32.5. IONS's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 59% of stocks. Ionis Pharmaceuticals Inc has fallen 5.67% over the past month, closing at $36.19 on September 20. During this period of time, the stock fell as low as $32.33 and as high as $37.47. IONS has an average analyst recommendation of Buy. The company has an average price target of $49.41.
IONS has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on IONS!